Estrogen Supplementation during Luteal Phase in IVF-ET Did Not Improve the Clinical Pregnancy Rate

Bing XU,Xiao-ming ZHAO,Yan HONG,Yun SUN,Zhong ZHENG,Wei-ping LI
DOI: https://doi.org/10.3969/j.issn.0253-357X.2008.02.007
2008-01-01
Abstract:Objective: To evaluate the impact of estrogen used as luteal support on clinical outcome of in vitro fertilization and embryo transfer(IVF-ET). Methods: 1) A total of 912 IVF-ET cycles were retrospectively analyzed. The clinical outcome was compared between two IVF-ET groups with different luteal support, group A (511 cycles) was supplied only progesterone (80 mg/d); group B (401cycles) was supplied progesterone (P, 80 mg/d) and estrogen (E2, 2 mg/d). 2) The clinical outcome in two groups which divided according to the E2(dhCG) / E2(dET) < 4.0 (291 cycles) and ≥4.0 (220 cycles). 3)The E2 level in the middle luteal phase was compared in IVF COH cycles and the nature cycles. Results: There was no difference in clinical outcome between the two groups with or without E2 supplied (P>0.05), two groups with different declined levels of E2 had the same outcome. The E2 level of IVF COH cycles was significant higher than that of nature cycles. Conclusion: The declined level of E2 did not affect the clinical outcome of IVF-ET and there was no beneficial effect in adding estrogen to luteal support.
What problem does this paper attempt to address?